EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis

Jung-Yu Kan, Shen-Liang Shih iD, Sheau-Fang Yang iD, Pei-Yi Chu iD, Fang-Ming Chen, Chung-Liang Li, Yi-Chia Wu, Yao-Tsung Yeh iD, Ming-Feng Hou iD, Chih-Po Chiang iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25021295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jung-Yu Kan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756,…. Hauptthemen laut MEDLINE: Biomarkers, Breast Neoplasms, Exosomes, MicroRNAs. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, Kaohsiung Medical University Hospital, Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomal microRNAs (miRNAs) are novel, non-invasive biomarkers for facilitating communication and diagnosing cancer. However, only a few studies have investigated their function and role in the clinical diagnosis of breast cancer. To address this gap, we established a stable cell line, MDA-MB-231-CD63-RFP, and recruited 112 female participants for serum collection. We screened 88 exosomal miRNAs identified through microarray analysis of 231-CD63 and literature screening using real-time PCR; only exosomal miR-92b-5p was significantly increased in patients with breast cancer. It had a significant correlation with stage and discriminated patients from the control with an AUC of 0.787. Exosomal miR-92b-5p impacted the migration, adhesion, and spreading ability of normal human mammary epithelial recipient cells through the downregulation of the actin dynamics regulator MTSS1L. In clinical breast cancer tissue, the expression of MTSS1L was significantly inversely correlated with tissue miR-92b-5p, and high expression of MTSS1L was associated with better 10-year overall survival rates in patients undergoing hormone therapy. In summary, our studies demonstrated that exosomal miR-92b-5p might function as a non-invasive body fluid biomarker for breast cancer detection and provide a novel therapeutic strategy in the axis of miR-92b-5p to MTSS1L for controlling metastasis and improving patient survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersBreast NeoplasmsExosomesMicroRNAsFemaleHumansCell Line, TumorCell Transformation, NeoplasticNeoplasm ProteinsMicrofilament Proteins

Stichwörter der Autor:innen

MTSS1Lbreast cancerexosomesmiR-92bmiRNAs

Substanzen

BiomarkersMicroRNAsNeoplasm ProteinsMIRN92 microRNA, humanMTSS1 protein, humanMicrofilament Proteins

Autor:innen und Institutionen

  • Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
  • Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
  • Department of Pathology, Show Chwan Memorial Hospital, Changhua 50544, Taiwan.
  • Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
  • Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung 83130, Taiwan.
  • Department of Biomedical Science and Environmental Biology, College of Life Science, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.

ORCID-Profile: Shen-Liang Shih, Sheau-Fang Yang, Pei-Yi Chu, Yao-Tsung Yeh, Ming-Feng Hou, Chih-Po Chiang

Förderung

  • Ministry of Health and Welfare
  • Kaohsiung Medical University Hospital
  • Ministry of Science and Technology

Zitieren

APA

Kan, J. Y., Shih, S. L., Yang, S. F., Chu, P. Y., Chen, F. M., Li, C. L., Wu, Y. C., Yeh, Y. T., Hou, M. F., & Chiang, C. P. (2024). Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25021295

Vancouver

Kan JY, Shih SL, Yang SF, Chu PY, Chen FM, Li CL, et al. Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021295

BibTeX
@article{Kan2024,
  author = {Kan, Jung-Yu and Shih, Shen-Liang and Yang, Sheau-Fang and Chu, Pei-Yi and Chen, Fang-Ming and Li, Chung-Liang and Wu, Yi-Chia and Yeh, Yao-Tsung and Hou, Ming-Feng and Chiang, Chih-Po},
  title = {Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25021295}
}
Kostenlos starten →